C. Mouchoux

发表

Can Hospital Discharge Databases Be Used to Follow Ischemic Stroke Incidence?

N. Nighoghossian, A. Schott, L. Mechtouff, 2013, Stroke.

A multi-center, randomized, controlled trial to assess the efficacy of optimization of drug prescribing in an elderly population, at 18 months of follow-up, in the evolution of functional autonomy: the OPTIM study protocol

P. Krolak-Salmon, E. Jean-bart, C. Mouchoux, 2017, BMC Geriatrics.

Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies

D. Osrin, H. Ayles, M. De Allegri, 2015, Trials.

Nursing Staff Knowledge on Postoperative Delirium in Older Inpatients: An Exploratory Survey

B. Comte, T. Fassier, P. Krolak-Salmon, 2016 .

A Standard International Version of the Drug Burden Index for Cross‐National Comparison of the Functional Burden of Medications in Older People

P. Krolak-Salmon, C. Mouchoux, V. Dauphinot, 2013, Journal of the American Geriatrics Society.

Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks.

C. Mouchoux, A. Janoly-Dumenil, F. Ranchon, 2021, Research in social & administrative pharmacy : RSAP.

Caregiver in Alzheimer's disease, pharmacist, and pharmacy technician attitudes and knowledge about caregiver burden screening in community pharmacies.

C. Mouchoux, V. Dauphinot, M. Chomel, 2019, Annales pharmaceutiques francaises.

One-Year Evolution of Behavioral and Psychological Symptoms of Dementia in Patients Initially Hospitalized in Cognitive Behavioral Units: The EVITAL Prospective Cohort.

B. Laurent, J. Dorey, P. Krolak-Salmon, 2017, Journal of Alzheimer's disease : JAD.

Detection of potentially inappropriate medication in a French geriatric teaching hospital: A comparison study of the French Beers criteria and the improved prescribing in the elderly tool

P. Krolak-Salmon, C. Mouchoux, A. Fouquet, 2012 .

Impact of a multifaceted program to prevent postoperative delirium in the elderly: the CONFUCIUS stepped wedge protocol

B. Comte, M. Bonnefoy, T. Fassier, 2011, BMC geriatrics.

How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)?

C. Rioufol, S. Goutelle, L. Bourguignon, 2021, Clinical interventions in aging.

Evolution in the dispensation of drugs for Alzheimer's disease after removal from the list of reimbursable drugs in France

P. Krolak-Salmon, C. Mouchoux, T. Novais, 2021, Journal of the American Geriatrics Society.

Potentially inappropriate medications and anticholinergic and sedative burden in older patients with haemophilia or von Willebrand disease: The M’HEMORRH‐AGE study

V. Chamouard, C. Mouchoux, A. Cransac, 2022, Journal of clinical pharmacy and therapeutics.

Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2017, Alzheimer's Research & Therapy.

Impact of collaborative pharmaceutical care on in-patients’ medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study)

S. Andrieu, P. Landais, B. Allenet, 2018, Trials.

How to explore the needs of informal caregivers of individuals with cognitive impairment in Alzheimer’s disease or related diseases? A systematic review of quantitative and qualitative studies

P. Krolak-Salmon, P. Krolak-Salmon, C. Mouchoux, 2017, BMC Geriatrics.

Relationship Between Comorbidities in Patients With Cognitive Complaint and Caregiver Burden: A Cross-Sectional Study.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.

Neurocognitive disorders: what are the prioritized caregiver needs? A consensus obtained by the Delphi method

P. Krolak-Salmon, C. Mouchoux, M. Kossovsky, 2018, BMC Health Services Research.

Exposure to Anticholinergic and Sedative Drugs, Risk of Falls, and Mortality: An Elderly Inpatient, Multicenter Cohort

P. Krolak-Salmon, S. Goutelle, L. Bourguignon, 2014, Journal of clinical psychopharmacology.

A multicenter cohort study to investigate the factors associated with functional autonomy change in patients with cognitive complaint or neurocognitive disorders: the MEMORA study protocol

P. Krolak-Salmon, C. Mouchoux, I. Rouch, 2019, BMC Geriatrics.

Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study.

P. Krolak-Salmon, C. Mouchoux, I. Rouch, 2015, Journal of Alzheimer's disease : JAD.

[Role of clinical pharmacist in the therapeutical optimization in geriatric outpatient hospital].

P. Krolak-Salmon, E. Jean-bart, C. Mouchoux, 2014, Annales Pharmaceutiques Françaises.

[Pharmacist's interventions on proton pump inhibitor prescriptions in a University Hospital].

C. Mouchoux, B. Charpiat, A. Janoly-Dumenil, 2015, Journal de pharmacie de Belgique.

[Emergent adverse effects of proton pump inhibitors].

C. Mouchoux, B. Charpiat, A. Janoly-Dumenil, 2013, Presse medicale.

S. Goutelle, C. Mouchoux, D. Cabelguenne, 2021, Annales pharmaceutiques francaises.

Factors associated with changes in exposure to anticholinergic and sedative medications in elderly hospitalized patients: multicentre longitudinal study

P. Krolak-Salmon, S. Goutelle, L. Bourguignon, 2017, European journal of neurology.

Medication exposure and frailty in older community-dwelling patients: a cross-sectional study

P. Krolak-Salmon, C. Mouchoux, V. Dauphinot, 2020, International Journal of Clinical Pharmacy.

P. Krolak-Salmon, E. Morelon, C. Mouchoux, 2021, Nephrologie & therapeutique.

Risk Factors of Caregiver Burden Evolution, for Patients With Subjective Cognitive Decline or Neurocognitive Disorders: A Longitudinal Analysis.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.

Exposure to Anticholinergic and Sedative Drugs and Healthcare Costs in Older Patients with Neurocognitive Disorders.

P. Krolak-Salmon, C. Mouchoux, V. Dauphinot, 2021, Journal of Alzheimer's disease : JAD.

Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly

P. Krolak-Salmon, E. Jean-bart, C. Mouchoux, 2017, International Journal of Clinical Pharmacy.

Clinical, economic, and organizational impact of pharmacists’ interventions in a cognitive-behavioral unit in France

P. Krolak-Salmon, C. Mouchoux, M. Grail, 2020, International Journal of Clinical Pharmacy.

Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2017, Alzheimer's Research & Therapy.

PHARMAID study protocol: Randomized controlled trial to assess the impact of integrated pharmaceutical care at a psychosocial intervention on caregiver's burden in Alzheimer's disease or related diseases.

P. Krolak-Salmon, C. Colin, C. Mouchoux, 2017, Contemporary clinical trials.

Can Hospital Discharge Databases Be Used to Follow Ischemic Stroke Incidence ?

N. Nighoghossian, L. Mechtouff, L. Derex, 2022 .

Medication exposure of the dyad patient-caregiver in Alzheimer's disease and related dementias: a cross-sectional study.

H. Villars, P. Krolak-Salmon, B. Décaudin, 2023, International journal of clinical pharmacy.

[Medication management of hypertension and heart failure in older patients: What happens to therapeutic changes after hospitalization?]

C. Mouchoux, Z. Makaroff, J. Mercier, 2020, Annales de cardiologie et d'angeiologie.

Description of the Treatment Course by Pregabalin for Anxiety in Patients With a Major Neurocognitive Disorder

P. Krolak-Salmon, C. Mouchoux, A. Lepetit, 2019, Journal of clinical psychopharmacology.

Relationship Between Comorbidities in Patients With Cognitive Complaint and Caregiver Burden: A Cross-Sectional Study.

P. Krolak-Salmon, C. Mouchoux, F. Delphin-Combe, 2016, Journal of the American Medical Directors Association.